S. Rogers
University of Sheffield
13 Papers
318 Citations
S. Rogers is an academic researcher from University of Sheffield. The author has contributed to research in topics: Male Breast Carcinoma & Medicine. The author has an hindex of 11, co-authored 13 publications. Previous affiliations of S. Rogers include University of Wales.
Chat about Author
Papers
Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis
S. Khan,John A. Kanis,Samuel D Vasikaran,W. F. Kline,Bogdan K. Matuszewski,Eugene V. McCloskey,Monique N.C. Beneton,Barry J. Gertz,David G. Sciberras,Sherry D. Holland,J. Orgee,G. Coombes,S. Rogers,Arturo G. Porras +13 more
TL;DR: It is concluded that a short course of high doses of intravenous alendronate is associated with a prolonged skeletal retention of the agent, and suggests that this regimen has a sustained effect on bone turnover persisting for at least 1 year.
302
Comparison of response to injury in organ culture of human saphenous vein and internal mammary artery.
Cathy M. Holt,Cathy M. Holt,Sheila E. Francis,Sheila E. Francis,Andrew C. Newby,Andrew C. Newby,S. Rogers,S. Rogers,P Gadsdon,P Gadsdon,T Taylor,T Taylor,Gianni D Angelini,Gianni D Angelini +13 more
TL;DR: The data show that although the smooth muscle proliferation was similar in undamaged saphenous vein and internal mammary artery, it was significantly greater in damaged vein, which implies that the greater intimal proliferation seen in sa phenous vein grafts may arise not from intrinsic differences in arterial and venous smooth muscle cells but from a greater susceptibility to injury.
69
Alendronate in the treatment of Paget's disease of bone
S. Khan,Samuel D Vasikaran,Eugene V. McCloskey,Monique N.C. Beneton,S. Rogers,Les Coulton,J. Orgee,G. Coombes,John A. Kanis +8 more
TL;DR: Oral alendronate is an effective agent for the treatment of Paget's disease of bone and Histomorphometric assessment showed a decrease in indices of bone turnover in the pagetic biopsies.
60
Release of platelet-derived growth factor activity from pig venous arterial grafts
Sheila E. Francis,Steven Hunter,Cathy M. Holt,P Gadsdon,S. Rogers,Gordon W. Duff,Andrew C. Newby,Gianni D Angelini +7 more
TL;DR: Data from cultured segments of pig venous arterial grafts constitute direct evidence for active growth factor production within the cells of the vein graft and suggest that endogenously produced platelet-derived growth factor may play a role in regulating smooth muscle cell proliferation in this model.
55
Lack of c-erbB-2 oncoprotein expression in male breast carcinoma.
TL;DR: All male breast carcinomas were immunostained using NCL-CB11, an antibody directed against the internal domain of the c-erbB-2 transmembrane oncoprotein, and all of these cases were negative, suggesting that no prognostic information regarding patient survival can be made in these patients.
42